Bixiye
P65-21 Change in Claim Submission for Medicare Members for COVID-19 Vaccines and Monoclonal Antibody Treatment
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Natiijooyinka Raadinta
Soo bandhiga 1461 - 1470 ee natiijooyinka 4296
Bixiye
P66-21 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective January 3, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P67-21 Medical Drug Policy Update – Infliximab Preferred Product Expansion to Include Remicade, Inflectra, and Renflexis
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P68-21 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P69-21 eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P70-21 New: eviCore Durable Medical Equipment (DME) Supplementary Guidelines for Medicare Advantage Subscribers
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P71-21 Updated Minnesota Health Care Programs and Minnesota Senior Health Options (MSHO) Prior Authorization and Medical Policy Requirements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P72-21 Introducing Coupe Health
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P73-21 Update to Reimbursement Policy Lab Path Services - 002 Professional Component for Pathology Test
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021
Bixiye
P74-21 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans Managed by Blue Cross and Blue Shield of Alabama
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2021